Free Trial

MultiPlan (MPLN) Competitors

MultiPlan logo
$20.32 -1.20 (-5.58%)
As of 04/16/2025

MPLN vs. IBTA, NEO, LZ, UPBD, APLD, DFIN, TASK, EVH, XMTR, and FLYW

Should you be buying MultiPlan stock or one of its competitors? The main competitors of MultiPlan include Ibotta (IBTA), NeoGenomics (NEO), LegalZoom.com (LZ), Upbound Group (UPBD), Applied Digital (APLD), Donnelley Financial Solutions (DFIN), TaskUs (TASK), Evolent Health (EVH), Xometry (XMTR), and Flywire (FLYW). These companies are all part of the "business services" industry.

MultiPlan vs.

MultiPlan (NYSE:MPLN) and Ibotta (NYSE:IBTA) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their profitability, media sentiment, earnings, dividends, analyst recommendations, community ranking, risk, valuation and institutional ownership.

MultiPlan currently has a consensus target price of $26.25, indicating a potential upside of 29.18%. Ibotta has a consensus target price of $50.00, indicating a potential upside of 9.15%. Given MultiPlan's higher probable upside, analysts clearly believe MultiPlan is more favorable than Ibotta.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
MultiPlan
0 Sell rating(s)
2 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
Ibotta
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

87.2% of MultiPlan shares are held by institutional investors. 8.0% of MultiPlan shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Ibotta has a net margin of 0.00% compared to MultiPlan's net margin of -163.30%. Ibotta's return on equity of 0.00% beat MultiPlan's return on equity.

Company Net Margins Return on Equity Return on Assets
MultiPlan-163.30% -12.14% -1.84%
Ibotta N/A N/A N/A

In the previous week, Ibotta had 15 more articles in the media than MultiPlan. MarketBeat recorded 16 mentions for Ibotta and 1 mentions for MultiPlan. MultiPlan's average media sentiment score of 1.79 beat Ibotta's score of -0.09 indicating that MultiPlan is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
MultiPlan
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
Ibotta
0 Very Positive mention(s)
1 Positive mention(s)
11 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Neutral

Ibotta has lower revenue, but higher earnings than MultiPlan. MultiPlan is trading at a lower price-to-earnings ratio than Ibotta, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
MultiPlan$930.62M0.35-$91.70M-$101.54-0.20
Ibotta$367.25M3.48$49.91M$1.7925.59

MultiPlan received 9 more outperform votes than Ibotta when rated by MarketBeat users. However, 100.00% of users gave Ibotta an outperform vote while only 35.71% of users gave MultiPlan an outperform vote.

CompanyUnderperformOutperform
MultiPlanOutperform Votes
10
35.71%
Underperform Votes
18
64.29%
IbottaOutperform Votes
1
100.00%
Underperform Votes
No Votes

Summary

Ibotta beats MultiPlan on 11 of the 17 factors compared between the two stocks.

Remove Ads
Get MultiPlan News Delivered to You Automatically

Sign up to receive the latest news and ratings for MPLN and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MPLN vs. The Competition

MetricMultiPlanBusiness services IndustryMedical SectorNYSE Exchange
Market Cap$328.60M$19.25B$5.29B$18.43B
Dividend YieldN/A2.93%5.11%4.22%
P/E Ratio-0.2131.7621.7131.10
Price / Sales0.356.94379.1226.38
Price / Cash1.6432.3038.1517.54
Price / Book0.194.936.434.30
Net Income-$91.70M$676.42M$3.21B$1.02B
7 Day Performance3.20%2.40%5.23%2.90%
1 Month Performance1.35%-9.47%-9.53%-7.77%
1 Year PerformanceN/A13.46%10.99%2.31%

MultiPlan Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MPLN
MultiPlan
1.7482 of 5 stars
$20.32
-5.6%
$26.25
+29.2%
N/A$328.60M$930.62M-0.21170Positive News
Gap Up
IBTA
Ibotta
0.4067 of 5 stars
$46.26
+0.5%
$50.00
+8.1%
N/A$1.29B$367.25M25.84N/AAnalyst Forecast
Short Interest ↑
News Coverage
NEO
NeoGenomics
2.5618 of 5 stars
$9.72
+4.3%
$19.60
+101.6%
-31.0%$1.25B$660.57M-15.682,100Analyst Forecast
High Trading Volume
LZ
LegalZoom.com
3.2135 of 5 stars
$7.09
-0.6%
$9.19
+29.6%
-42.1%$1.25B$681.88M54.541,220Analyst Forecast
Short Interest ↑
Positive News
UPBD
Upbound Group
4.3072 of 5 stars
$21.12
+0.8%
$37.00
+75.2%
-34.3%$1.21B$4.32B9.5612,700Positive News
APLD
Applied Digital
3.1946 of 5 stars
$5.37
+1.5%
$12.11
+125.5%
+66.5%$1.20B$211.62M-3.10121Earnings Report
Analyst Forecast
Analyst Revision
News Coverage
Gap Down
DFIN
Donnelley Financial Solutions
3.6937 of 5 stars
$40.98
+2.0%
$71.33
+74.1%
-33.3%$1.17B$781.90M13.392,150Analyst Forecast
Positive News
High Trading Volume
TASK
TaskUs
3.0493 of 5 stars
$12.75
+2.2%
$17.86
+40.1%
+20.6%$1.15B$994.99M21.6149,500Short Interest ↓
Positive News
EVH
Evolent Health
2.8007 of 5 stars
$9.82
-2.1%
$17.64
+79.7%
-69.4%$1.14B$2.55B-11.985,100
XMTR
Xometry
2.5097 of 5 stars
$21.49
+0.0%
$36.11
+68.0%
+35.4%$1.08B$545.53M-20.47790Positive News
FLYW
Flywire
3.7936 of 5 stars
$8.65
+1.4%
$17.00
+96.5%
-57.5%$1.07B$492.14M57.67660Analyst Forecast
Remove Ads

Related Companies and Tools


This page (NYSE:MPLN) was last updated on 4/17/2025 by MarketBeat.com Staff
From Our Partners